Publication | Closed Access

Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial

Islatravir Subdermal ImplantTreatment And PreventionHuman RetrovirusHiv-1 Pre-exposure ProphylaxisAntiviral TherapyBiomedical EngineeringAntiviral DrugHivMedicinePlacebo-controlled Phase 1Aids Pathogenesis